Diseases, Conditions, Syndromes

Has Delta killed the herd immunity dream?

As the Delta variant continues its global surge, experts are questioning whether the long-held goal of achieving herd immunity from COVID-19 through vaccination is still viable.

Oncology & Cancer

Enhanced melanoma vaccine offers improved survival for men

A second-generation melanoma vaccine being developed at UVA Cancer Center improves long-term survival for melanoma patients compared with the first-generation vaccine, new research shows. Interestingly, the benefit of the ...

page 4 from 40